[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content
Log in

Binding of rifampicin by human plasma proteins

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The binding of rifampicin to human plasma proteins has been investigated by equilibrium dialysis. Plasma from eleven healthy subjects not taking drugs bound 87–91% of added rifampicin. Binding was lower (84–88%) in plasma from ten tuberculous patients on long-term treatment with rifampicin. Physiological concentrations of human albumin, gamma globulin and fibrinogen bound 41, 10 and 8%, respectively, of added rifampicin. Isoniazid, p-aminosalicylic acid, streptomycin and ethambutol did not significantly affect rifampicin binding to plasma proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aoyagi, T.: Protein binding of rifampicin to different individual sera. Scand. J. resp. Dis. (Suppl. 84), 44–49 (1973)

    Google Scholar 

  • Beeuwkes, H., Buytendijk, H. J., Maesen, F. P. V.: Der Wert des Rifampicin bei der Behandlung von Patienten mit bronchopulmonären Affektionen. Arzneimittel-Forsch.19, 1283–1285 (1969)

    Google Scholar 

  • Binda, G., Domenichini, E., Gottardi, A., Orlandi, B., Ortelli, E., Pacini, B., Fowst, G.: Rifampicin, a general review. Arzneimittel-Forsch.21, 1907–1978 (1971)

    Google Scholar 

  • Boman, G., Hanngren, Å., Malmborg, A.-S., Borgå, O., Sjöqvist, F.: Drug interaction: decreased serum concentrations of rifampicin when given with P.A.S. Lancet1971 I, 800

    Google Scholar 

  • Boman, G.: Protein binding of rifampicin. A review. Scand. J. resp. Dis. Suppl.84, 40–43 (1973)

    Google Scholar 

  • Boman, G.: Serum concentration and half-live of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid. Europ. J. clin. Pharmacol.7, 217–225 (1974)

    Google Scholar 

  • Boman, G., Malmborg, A.-S.: Rifampicin in plasma and pleural fluid after single oral doses. Europ. J. clin. Pharmacol.7, 51–58 (1974)

    Google Scholar 

  • Borgå, O., Azarnoff, D. L., Sjöqvist, F.: Species differences in the plasma protein binding of desipramine. J. Pharm. Pharmacol.20, 571–572 (1968)

    Google Scholar 

  • Chignell, C. F., Starkweather, D. K.: Species differences in the binding of phenylbutazone to plasma albumin. Pharmacology5, 235–244 (1971)

    Google Scholar 

  • Curci, G., Ninni, A., D'Alessio, A., Iodice, F.: Interferenze fisico-chimiche a livello del legame proteico fra PAS ed altri chemioterapici. XIX Congresso Italiano di Tisiologia3, 955–957 (1968)

    Google Scholar 

  • Dost, F. H.: Grundlagen der Pharmakokinetik, pp. 106–108. Stuttgart: Thieme 1968

    Google Scholar 

  • Doumas, B. T., Watson, W. A., Biggs, H. G.: Albumin standards and the measurement of serum albumin with bromcresol green. Clin. chim. Acta31, 87–96 (1971)

    Google Scholar 

  • Dukor, P., Schumann, G., Dietrich, F. M.: Immunological studies with rifampicin. Scand. J. resp. Dis. (Suppl. 84), 73–82 (1973)

    Google Scholar 

  • Ehrnebo, M., Agurell, S., Jalling, B., Boréus, L. O.: Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults. Europ. J. clin. Pharmacol.3, 189–193 (1971)

    Google Scholar 

  • Guiliano, V., Ninni, A.: Indagini sul legame delle rifamicine SV ed AMP con le proteine del siero. XVIII Congresso Italiano di Tisiologia2, 154–155 (1966)

    Google Scholar 

  • Gundert-Remy, U., Klett, M., Weber, E.: Concentration of ethambutol in cerebrospinal fluid in man as a function of the non-protein-bound drug fraction in serum. Europ. J. clin. Pharmacol.6, 133–136 (1973)

    Google Scholar 

  • Lunde, P. K. M., Rane, A., Yaffe, S. J., Lund, L., Sjöqvist, F.: Plasma protein binding of diphenylhydantoin in man. Clin. Pharmacol. Ther.11, 846–855 (1970)

    Google Scholar 

  • Mashimo, K.: Rifampicin: pharmacological and clinical studies. Prog. Antimicrob. Anticancer Chemother.2, 1198–1205. Baltimore: University Park Press 1970

    Google Scholar 

  • Nilsson, B. S., Boman, G., Bullock, W. W.: Detection of rifampicin binding immunoglobulins. Scand. J. resp. Dis. (Suppl. 84), 50–52 (1973)

    Google Scholar 

  • Riess, W.: The optimum dosage schedule for Rimactane. A symposium on Rimactane, pp. 36–42. Basel: CIBA 1968

    Google Scholar 

  • Riess, W., Schmid, K., Keberle, H., Dettli, L., Spring, P.: Pharmacokinetic studies in the field of rifamycins. Prog. Antimicrob. Anticancer Chemother.2, 905–913. Baltimore: University Park Press 1970

    Google Scholar 

  • Sato, S., Motomiya, M., Amizuka, T., Fumakoshi, H.: Binding of streptomycin, paraaminosalicylic acid and isonicotinic acid to serum protein. Sci. Rep. Res. Inst. Tohoku Univ.8, 111–135 (1958)

    Google Scholar 

  • Seydel, J. K.: Physico-chemical studies on rifampicin. Antibiot. et Chemother. (Basel)16, 380–391 (1970)

    Google Scholar 

  • Stockholm Workshop on Rifampicin, 1972. Scand. J. resp. Dis. Suppl. 84 (1973)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boman, G., Ringberger, V.A. Binding of rifampicin by human plasma proteins. Eur J Clin Pharmacol 7, 369–373 (1974). https://doi.org/10.1007/BF00558209

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00558209

Key words

Navigation